We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MAGN:NYSEMagnera Corporation Analysis

Data as of 2026-06-18 - not real-time

$12.03

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Magnera’s stock is trading close to its technical support level, with the short‑term moving average just edging above the longer‑term average, suggesting a subtle bullish bias. The RSI sits in the upper‑mid range, indicating momentum is still intact, while the MACD histogram remains positive, reinforcing the bullish signal. However, the 30‑day volatility is elevated and the beta is well above one, flagging heightened price swings relative to the market. Fundamentals show declining revenue, thin gross margins and a negative trailing EPS, underscoring ongoing profitability challenges. Yet the discounted cash flow model projects a fair value substantially higher than the current price, implying a notable upside potential.
The recent launch of the Universa line of industrial wipers adds a fresh growth catalyst that could improve top‑line momentum, but the company remains unprofitable and carries a high debt load, limiting financial flexibility. With no dividend and a low price‑to‑book ratio, the stock appears attractively priced from a value standpoint, though investors must weigh the operational turnaround risk. Overall, the blend of technical support, undervalued valuation, and product‑line expansion creates a cautiously optimistic outlook tempered by earnings volatility and sector‑specific regulatory exposure.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Technical support near current price
  • Bullish MACD but high short‑term volatility
  • Negative earnings and thin margins

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Undervalued relative to DCF fair value
  • Potential revenue boost from new Universa product line
  • Improving cash flow generation

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Significant upside potential if turnaround succeeds
  • Low price‑to‑book and price‑to‑sales multiples
  • Defensive consumer sector cushioning against cycles

Key Metrics & Analysis

Financial Health

Revenue Growth-3.40%
Profit Margin-3.37%
P/E Ratio7.1
ROE-10.32%
ROA1.98%
Debt/Equity188.55
P/B Ratio0.4
Op. Cash Flow$185.0M
Free Cash Flow$201.0M

Technical Analysis

TrendNeutral
RSI58.7
Support$10.16
Resistance$13.00
MA 20$11.58
MA 50$10.95
MA 200$11.71
MACDBullish
VolumeStable
Fear & Greed Index91.18

Valuation

Fair Value$28.42
Target Price$14.50
Upside/Downside20.53%
GradeUndervalued
TypeValue

Risk Assessment

Beta1.45
Volatility47.15%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.